Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Molecular basis of V-ATPase inhibition by bafilomycin A1.

Tytuł:
Molecular basis of V-ATPase inhibition by bafilomycin A1.
Autorzy:
Wang R; Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Wang J; Eugene McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Hassan A; Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Lee CH; Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Xie XS; Eugene McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center, Dallas, TX, USA. .
Li X; Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX, USA. .; Department of Biophysics, University of Texas Southwestern Medical Center, Dallas, TX, USA. .
Źródło:
Nature communications [Nat Commun] 2021 Mar 19; Vol. 12 (1), pp. 1782. Date of Electronic Publication: 2021 Mar 19.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
Język:
English
Imprint Name(s):
Original Publication: [London] : Nature Pub. Group
MeSH Terms:
Macrolides/*pharmacology
Vacuolar Proton-Translocating ATPases/*antagonists & inhibitors
Amino Acid Sequence ; Animals ; Binding Sites ; Biocatalysis/drug effects ; Cattle ; Cryoelectron Microscopy ; Enzyme Inhibitors/chemistry ; Enzyme Inhibitors/metabolism ; Enzyme Inhibitors/pharmacology ; Macrolides/chemistry ; Macrolides/metabolism ; Models, Molecular ; Molecular Structure ; Protein Binding ; Protein Domains ; Sequence Homology, Amino Acid ; Vacuolar Proton-Translocating ATPases/chemistry ; Vacuolar Proton-Translocating ATPases/ultrastructure
References:
J Biol Chem. 2019 Apr 19;294(16):6439-6449. (PMID: 30792311)
J Biol Chem. 2004 Aug 6;279(32):33131-8. (PMID: 15180988)
Science. 2017 Nov 10;358(6364):807-813. (PMID: 29074583)
Mol Cancer. 2018 Feb 15;17(1):41. (PMID: 29448933)
Proc Natl Acad Sci U S A. 2019 Apr 9;116(15):7272-7277. (PMID: 30910982)
Sci Adv. 2020 Oct 7;6(41):. (PMID: 33028525)
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21. (PMID: 20124702)
Nature. 2016 Nov 3;539(7627):118-122. (PMID: 27776355)
Science. 2019 Aug 23;365(6455):. (PMID: 31439765)
Mol Cell. 2020 Nov 5;80(3):501-511.e3. (PMID: 33065002)
Cell Struct Funct. 1998 Feb;23(1):33-42. (PMID: 9639028)
Pflugers Arch. 2009 Jan;457(3):589-98. (PMID: 18026982)
Proc Natl Acad Sci U S A. 1986 Dec;83(23):8913-7. (PMID: 2878429)
Nat Rev Mol Cell Biol. 2007 Nov;8(11):917-29. (PMID: 17912264)
Nature. 2020 May;581(7808):339-343. (PMID: 32433613)
Physiol Rev. 2016 Jul;96(3):1071-91. (PMID: 27335445)
Nat Commun. 2020 Aug 6;11(1):3921. (PMID: 32764564)
J Biol Chem. 2006 Oct 20;281(42):31885-93. (PMID: 16912037)
J Comput Chem. 2004 Oct;25(13):1605-12. (PMID: 15264254)
Nature. 2015 May 14;521(7551):241-5. (PMID: 25971514)
J Struct Biol. 2015 Nov;192(2):216-21. (PMID: 26278980)
J Biol Chem. 1994 Jul 1;269(26):17379-81. (PMID: 8021236)
Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):12-21. (PMID: 20057044)
Acta Crystallogr D Biol Crystallogr. 1997 May 1;53(Pt 3):240-55. (PMID: 15299926)
J Biol Chem. 2002 Oct 25;277(43):40544-8. (PMID: 12186879)
BMC Biochem. 2005 Aug 04;6:13. (PMID: 16080788)
J Biol Chem. 2014 Jun 6;289(23):16399-408. (PMID: 24795045)
Nat Methods. 2015 Oct;12(10):943-6. (PMID: 26280328)
Nat Methods. 2020 Mar;17(3):328-334. (PMID: 32042190)
Development. 2010 Jun;137(11):1825-32. (PMID: 20460366)
J Biol Chem. 1986 Feb 25;261(6):2492-5. (PMID: 2869030)
Science. 2010 Jan 22;327(5964):459-63. (PMID: 20093472)
Mol Cell. 2020 Nov 5;80(3):379-380. (PMID: 33157012)
Proc Natl Acad Sci U S A. 1988 Nov;85(21):7972-6. (PMID: 2973058)
Trends Biochem Sci. 2015 Oct;40(10):611-622. (PMID: 26410601)
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32. (PMID: 15572765)
Elife. 2018 Nov 09;7:. (PMID: 30412051)
J Biol Chem. 2004 May 7;279(19):19755-63. (PMID: 14998996)
Theranostics. 2018 Oct 26;8(19):5379-5399. (PMID: 30555553)
Trends Biochem Sci. 1997 Nov;22(11):420-3. (PMID: 9397682)
J Biol Chem. 1994 Dec 2;269(48):30364-9. (PMID: 7982950)
Science. 2020 Mar 13;367(6483):1240-1246. (PMID: 32165585)
Trends Biochem Sci. 2020 Apr;45(4):295-307. (PMID: 32001091)
Nat Methods. 2017 Apr;14(4):331-332. (PMID: 28250466)
Nature. 2020 Jul;583(7816):459-468. (PMID: 32353859)
Protein Sci. 2018 Jan;27(1):14-25. (PMID: 28710774)
Protein Sci. 2017 May;26(5):896-909. (PMID: 28247968)
Cancer Med. 2018 Aug;7(8):3800-3811. (PMID: 29926527)
J Exp Biol. 2009 Feb;212(Pt 3):341-6. (PMID: 19151208)
Proc Natl Acad Sci U S A. 2012 Aug 28;109(35):13961-5. (PMID: 22869738)
Mol Cell. 2018 Mar 15;69(6):993-1004.e3. (PMID: 29526695)
Grant Information:
P01 HL020948 United States HL NHLBI NIH HHS; R01 GM135343 United States GM NIGMS NIH HHS; R01 HL072304 United States HL NHLBI NIH HHS
Substance Nomenclature:
0 (Enzyme Inhibitors)
0 (Macrolides)
88899-55-2 (bafilomycin A1)
EC 3.6.1.- (Vacuolar Proton-Translocating ATPases)
Entry Date(s):
Date Created: 20210320 Date Completed: 20210405 Latest Revision: 20240315
Update Code:
20240315
PubMed Central ID:
PMC7979754
DOI:
10.1038/s41467-021-22111-5
PMID:
33741963
Czasopismo naukowe
Pharmacological inhibition of vacuolar-type H + -ATPase (V-ATPase) by its specific inhibitor can abrogate tumor metastasis, prevent autophagy, and reduce cellular signaling responses. Bafilomycin A1, a member of macrolide antibiotics and an autophagy inhibitor, serves as a specific and potent V-ATPases inhibitor. Although there are many V-ATPase structures reported, the molecular basis of specific inhibitors on V-ATPase remains unknown. Here, we report the cryo-EM structure of bafilomycin A1 bound intact bovine V-ATPase at an overall resolution of 3.6-Å. The structure reveals six bafilomycin A1 molecules bound to the c-ring. One bafilomycin A1 molecule engages with two c subunits and disrupts the interactions between the c-ring and subunit a, thereby preventing proton translocation. Structural and sequence analyses demonstrate that the bafilomycin A1-binding residues are conserved in yeast and mammalian species and the 7'-hydroxyl group of bafilomycin A1 acts as a unique feature recognized by subunit c.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies